OvarianVax is the world’s first vaccine against ovarian cancer
Scientists from Oxford University received enough funds to develop first vaccine in the world against ovarian cancer. After achieving this result with breast cancer, there is more good news for science. According to Daniel Postico, are developing Ovarianvax to train the immune system to recognize and attack the early stages of this sixth most common disease in the UK.
Scientists identify specific proteins on the surface of ovarian cancer cells. This progress is already being compared to the success of the coronavirus vaccine. human papilloma. Once this phase is completed, the vaccine will move on to human clinical trials. They will first be carried out on people who carry genetic mutations such as BRCA1 and BRCA2. It is expected to be developed within three years and could be used across the NHS.
Oxford to develop first vaccine against ovarian cancer
45% of people with a mutation in BRCA1 gene and 20% with BRCA2 changes develop ovarian cancer before age 80. Now Oxford University scientists have secured funding to developWaxing ovaries‘. According to their website, women with these mutations are offered surgery, which prevents the disease but prevents them from having children.
“OvarianVax can offer solution For prevent cancer, primarily in high-risk women, but also more broadly if the trial is successful. With this funding, our research can take a big step towards creating a viable vaccine against ovarian cancer,” said Ahmed Ahmed, Director of the Ovarian Cancer Cell Laboratory at the MRC Weatherall Institute of Molecular Medicine at the University of Oxford.
They will teach the immune system to recognize more than 100 proteins.
Scientists have discovered that immune cells from ovarian cancer patients remember the tumor. And based on this they will teach immune system recognize more than 100 proteins on the surface of ovarian cancer. This way, they will determine which of these antigens cause the immune system to recognize and destroy cells that become cancerous.
Michelle Mitchell, chief executive of Cancer Research UK, said projects like this are another step forward in the science of predicting this type of cancer. And the goal of this project is to give women a longer life without fear of disease.